Global Medication

Medication Comprehensive Study by Type (Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics), Formulations (Chronic, Acute)), Application (Hospital, Clinic, Other), Sales Channels (Online Sales Channels, Offline Sales Channels) Players and Region - Global Market Outlook to 2024

Medication Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Medication Market Scope
The medication industry is incorporate with the companies includes research, developing, manufacturing and drug suppliers for human and veterinary use. There are many new drugs has a wide influence on global health, economy productivity preventing surgeries, shortening in hospitals, and other parameters. Rapid advancement in medication have banished deadly diseases and brought other life-threatening conditions in control.

The market study is being classified by Type (Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics) and Formulations (Chronic, Acute)), by Application (Hospital, Clinic and Other) and major geographies with country level break-up.

The global Medication market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Medication market throughout the predicted period.

Johnson & Johnson (United States), Novartis (Switzerland), Roche Holding AG (Switzerland), Pfizer (Switzerland), Sanofi (France), Merck (United States), GlaxoSmithKline (United Kingdom), AstraZeneca (United Kingdom), Bayer (Germany) and Gilead Sciences (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Amgen (United States), AstraZeneca (United Kingdom), Bristol-Myers Squibb (United States), Eli Lilly (United States), Teva Pharmaceutical (Israel), Novo Nordisk (Denmark), Allergan (Ireland), Shire (United States) and Takeda (Japan).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Medication market by Type, Application and Region.

On the basis of geography, the market of Medication has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channels, the sub-segment i.e. Online Sales Channels will boost the Medication market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In Sep 2018, Headspace announced the acquisition of artificial intelligence start-up known as Alpine.AI. This AI-based application reminds patients to take medication.
In Apr 2019, Eli Lilly and Company announced the approval of the Emgality injection for the treatment of cluster headache in adults by the United States Food and Drug Administration. This medication has the potential to help patients with episodic cluster headache conditions by reducing the frequency cluster attacks.


Market Trend
  • Low Cost Of Production and Increasing Research & Development Boost Efficiency of Pharma Companies
  • Technology Advancement in Medical Value Chain System

Market Drivers
  • Growing Pharmaceutical Industry in Volume Terms
  • Increase Penetration of Health Insurance
  • Rising Penetration of Chemists in Rural Areas
  • Increasing Stress-Related Diseases Due To Change in Lifestyle

Opportunities
  • Strong Opportunities for Drugs Providers Are Expected To Grow In Next Few Years, With Many Drugs Going Off-Patent in the United States Region
  • Growing Population and Income Levels in Emerging Countries Such As China and India, Demand for High-End Drugs Is Expected To Rise
  • High Adoption Rate for Generic Medicines in Rural Markets

Restraints
  • High Drugs Prices in the United States
  • High Distribution Cost

Challenges
  • Rapid Changes in Technology
  • Rising Cost of Raw Materials


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Medication Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics)
  • Formulations (Chronic, Acute)
By Application
  • Hospital
  • Clinic
  • Other
By Sales Channels
  • Online Sales Channels
  • Offline Sales Channels

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Pharmaceutical Industry in Volume Terms
      • 3.2.2. Increase Penetration of Health Insurance
      • 3.2.3. Rising Penetration of Chemists in Rural Areas
      • 3.2.4. Increasing Stress-Related Diseases Due To Change in Lifestyle
    • 3.3. Market Challenges
      • 3.3.1. Rapid Changes in Technology
      • 3.3.2. Rising Cost of Raw Materials
    • 3.4. Market Trends
      • 3.4.1. Low Cost Of Production and Increasing Research & Development Boost Efficiency of Pharma Companies
      • 3.4.2. Technology Advancement in Medical Value Chain System
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medication, by Type, Application, Sales Channels and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Medication (Value)
      • 5.2.1. Global Medication by: Type (Value)
        • 5.2.1.1. Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics)
        • 5.2.1.2. Formulations (Chronic, Acute)
      • 5.2.2. Global Medication by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Other
      • 5.2.3. Global Medication by: Sales Channels (Value)
        • 5.2.3.1. Online Sales Channels
        • 5.2.3.2. Offline Sales Channels
      • 5.2.4. Global Medication Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Medication (Volume)
      • 5.3.1. Global Medication by: Type (Volume)
        • 5.3.1.1. Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics)
        • 5.3.1.2. Formulations (Chronic, Acute)
      • 5.3.2. Global Medication by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. Other
      • 5.3.3. Global Medication by: Sales Channels (Volume)
        • 5.3.3.1. Online Sales Channels
        • 5.3.3.2. Offline Sales Channels
      • 5.3.4. Global Medication Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Medication (Price)
      • 5.4.1. Global Medication by: Type (Price)
  • 6. Medication: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche Holding AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanofi (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GlaxoSmithKline (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AstraZeneca (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bayer (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Gilead Sciences (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Medication Sale, by Type, Application, Sales Channels and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Medication (Value)
      • 7.2.1. Global Medication by: Type (Value)
        • 7.2.1.1. Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics)
        • 7.2.1.2. Formulations (Chronic, Acute)
      • 7.2.2. Global Medication by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Other
      • 7.2.3. Global Medication by: Sales Channels (Value)
        • 7.2.3.1. Online Sales Channels
        • 7.2.3.2. Offline Sales Channels
      • 7.2.4. Global Medication Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Medication (Volume)
      • 7.3.1. Global Medication by: Type (Volume)
        • 7.3.1.1. Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics)
        • 7.3.1.2. Formulations (Chronic, Acute)
      • 7.3.2. Global Medication by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. Other
      • 7.3.3. Global Medication by: Sales Channels (Volume)
        • 7.3.3.1. Online Sales Channels
        • 7.3.3.2. Offline Sales Channels
      • 7.3.4. Global Medication Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Medication (Price)
      • 7.4.1. Global Medication by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medication: by Type(USD Million)
  • Table 2. Medication Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics) , by Region USD Million (2013-2018)
  • Table 3. Medication Formulations (Chronic, Acute) , by Region USD Million (2013-2018)
  • Table 4. Medication: by Application(USD Million)
  • Table 5. Medication Hospital , by Region USD Million (2013-2018)
  • Table 6. Medication Clinic , by Region USD Million (2013-2018)
  • Table 7. Medication Other , by Region USD Million (2013-2018)
  • Table 8. Medication: by Sales Channels(USD Million)
  • Table 9. Medication Online Sales Channels , by Region USD Million (2013-2018)
  • Table 10. Medication Offline Sales Channels , by Region USD Million (2013-2018)
  • Table 11. South America Medication, by Country USD Million (2013-2018)
  • Table 12. South America Medication, by Type USD Million (2013-2018)
  • Table 13. South America Medication, by Application USD Million (2013-2018)
  • Table 14. South America Medication, by Sales Channels USD Million (2013-2018)
  • Table 15. Brazil Medication, by Type USD Million (2013-2018)
  • Table 16. Brazil Medication, by Application USD Million (2013-2018)
  • Table 17. Brazil Medication, by Sales Channels USD Million (2013-2018)
  • Table 18. Argentina Medication, by Type USD Million (2013-2018)
  • Table 19. Argentina Medication, by Application USD Million (2013-2018)
  • Table 20. Argentina Medication, by Sales Channels USD Million (2013-2018)
  • Table 21. Rest of South America Medication, by Type USD Million (2013-2018)
  • Table 22. Rest of South America Medication, by Application USD Million (2013-2018)
  • Table 23. Rest of South America Medication, by Sales Channels USD Million (2013-2018)
  • Table 24. Asia Pacific Medication, by Country USD Million (2013-2018)
  • Table 25. Asia Pacific Medication, by Type USD Million (2013-2018)
  • Table 26. Asia Pacific Medication, by Application USD Million (2013-2018)
  • Table 27. Asia Pacific Medication, by Sales Channels USD Million (2013-2018)
  • Table 28. China Medication, by Type USD Million (2013-2018)
  • Table 29. China Medication, by Application USD Million (2013-2018)
  • Table 30. China Medication, by Sales Channels USD Million (2013-2018)
  • Table 31. Japan Medication, by Type USD Million (2013-2018)
  • Table 32. Japan Medication, by Application USD Million (2013-2018)
  • Table 33. Japan Medication, by Sales Channels USD Million (2013-2018)
  • Table 34. India Medication, by Type USD Million (2013-2018)
  • Table 35. India Medication, by Application USD Million (2013-2018)
  • Table 36. India Medication, by Sales Channels USD Million (2013-2018)
  • Table 37. South Korea Medication, by Type USD Million (2013-2018)
  • Table 38. South Korea Medication, by Application USD Million (2013-2018)
  • Table 39. South Korea Medication, by Sales Channels USD Million (2013-2018)
  • Table 40. Taiwan Medication, by Type USD Million (2013-2018)
  • Table 41. Taiwan Medication, by Application USD Million (2013-2018)
  • Table 42. Taiwan Medication, by Sales Channels USD Million (2013-2018)
  • Table 43. Australia Medication, by Type USD Million (2013-2018)
  • Table 44. Australia Medication, by Application USD Million (2013-2018)
  • Table 45. Australia Medication, by Sales Channels USD Million (2013-2018)
  • Table 46. Rest of Asia-Pacific Medication, by Type USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Medication, by Application USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Medication, by Sales Channels USD Million (2013-2018)
  • Table 49. Europe Medication, by Country USD Million (2013-2018)
  • Table 50. Europe Medication, by Type USD Million (2013-2018)
  • Table 51. Europe Medication, by Application USD Million (2013-2018)
  • Table 52. Europe Medication, by Sales Channels USD Million (2013-2018)
  • Table 53. Germany Medication, by Type USD Million (2013-2018)
  • Table 54. Germany Medication, by Application USD Million (2013-2018)
  • Table 55. Germany Medication, by Sales Channels USD Million (2013-2018)
  • Table 56. France Medication, by Type USD Million (2013-2018)
  • Table 57. France Medication, by Application USD Million (2013-2018)
  • Table 58. France Medication, by Sales Channels USD Million (2013-2018)
  • Table 59. Italy Medication, by Type USD Million (2013-2018)
  • Table 60. Italy Medication, by Application USD Million (2013-2018)
  • Table 61. Italy Medication, by Sales Channels USD Million (2013-2018)
  • Table 62. United Kingdom Medication, by Type USD Million (2013-2018)
  • Table 63. United Kingdom Medication, by Application USD Million (2013-2018)
  • Table 64. United Kingdom Medication, by Sales Channels USD Million (2013-2018)
  • Table 65. Netherlands Medication, by Type USD Million (2013-2018)
  • Table 66. Netherlands Medication, by Application USD Million (2013-2018)
  • Table 67. Netherlands Medication, by Sales Channels USD Million (2013-2018)
  • Table 68. Rest of Europe Medication, by Type USD Million (2013-2018)
  • Table 69. Rest of Europe Medication, by Application USD Million (2013-2018)
  • Table 70. Rest of Europe Medication, by Sales Channels USD Million (2013-2018)
  • Table 71. MEA Medication, by Country USD Million (2013-2018)
  • Table 72. MEA Medication, by Type USD Million (2013-2018)
  • Table 73. MEA Medication, by Application USD Million (2013-2018)
  • Table 74. MEA Medication, by Sales Channels USD Million (2013-2018)
  • Table 75. Middle East Medication, by Type USD Million (2013-2018)
  • Table 76. Middle East Medication, by Application USD Million (2013-2018)
  • Table 77. Middle East Medication, by Sales Channels USD Million (2013-2018)
  • Table 78. Africa Medication, by Type USD Million (2013-2018)
  • Table 79. Africa Medication, by Application USD Million (2013-2018)
  • Table 80. Africa Medication, by Sales Channels USD Million (2013-2018)
  • Table 81. North America Medication, by Country USD Million (2013-2018)
  • Table 82. North America Medication, by Type USD Million (2013-2018)
  • Table 83. North America Medication, by Application USD Million (2013-2018)
  • Table 84. North America Medication, by Sales Channels USD Million (2013-2018)
  • Table 85. United States Medication, by Type USD Million (2013-2018)
  • Table 86. United States Medication, by Application USD Million (2013-2018)
  • Table 87. United States Medication, by Sales Channels USD Million (2013-2018)
  • Table 88. Canada Medication, by Type USD Million (2013-2018)
  • Table 89. Canada Medication, by Application USD Million (2013-2018)
  • Table 90. Canada Medication, by Sales Channels USD Million (2013-2018)
  • Table 91. Mexico Medication, by Type USD Million (2013-2018)
  • Table 92. Mexico Medication, by Application USD Million (2013-2018)
  • Table 93. Mexico Medication, by Sales Channels USD Million (2013-2018)
  • Table 94. Medication Sales: by Type(Million Units)
  • Table 95. Medication Sales Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics) , by Region Million Units (2013-2018)
  • Table 96. Medication Sales Formulations (Chronic, Acute) , by Region Million Units (2013-2018)
  • Table 97. Medication Sales: by Application(Million Units)
  • Table 98. Medication Sales Hospital , by Region Million Units (2013-2018)
  • Table 99. Medication Sales Clinic , by Region Million Units (2013-2018)
  • Table 100. Medication Sales Other , by Region Million Units (2013-2018)
  • Table 101. Medication Sales: by Sales Channels(Million Units)
  • Table 102. Medication Sales Online Sales Channels , by Region Million Units (2013-2018)
  • Table 103. Medication Sales Offline Sales Channels , by Region Million Units (2013-2018)
  • Table 104. South America Medication Sales, by Country Million Units (2013-2018)
  • Table 105. South America Medication Sales, by Type Million Units (2013-2018)
  • Table 106. South America Medication Sales, by Application Million Units (2013-2018)
  • Table 107. South America Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 108. Brazil Medication Sales, by Type Million Units (2013-2018)
  • Table 109. Brazil Medication Sales, by Application Million Units (2013-2018)
  • Table 110. Brazil Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 111. Argentina Medication Sales, by Type Million Units (2013-2018)
  • Table 112. Argentina Medication Sales, by Application Million Units (2013-2018)
  • Table 113. Argentina Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 114. Rest of South America Medication Sales, by Type Million Units (2013-2018)
  • Table 115. Rest of South America Medication Sales, by Application Million Units (2013-2018)
  • Table 116. Rest of South America Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 117. Asia Pacific Medication Sales, by Country Million Units (2013-2018)
  • Table 118. Asia Pacific Medication Sales, by Type Million Units (2013-2018)
  • Table 119. Asia Pacific Medication Sales, by Application Million Units (2013-2018)
  • Table 120. Asia Pacific Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 121. China Medication Sales, by Type Million Units (2013-2018)
  • Table 122. China Medication Sales, by Application Million Units (2013-2018)
  • Table 123. China Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 124. Japan Medication Sales, by Type Million Units (2013-2018)
  • Table 125. Japan Medication Sales, by Application Million Units (2013-2018)
  • Table 126. Japan Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 127. India Medication Sales, by Type Million Units (2013-2018)
  • Table 128. India Medication Sales, by Application Million Units (2013-2018)
  • Table 129. India Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 130. South Korea Medication Sales, by Type Million Units (2013-2018)
  • Table 131. South Korea Medication Sales, by Application Million Units (2013-2018)
  • Table 132. South Korea Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 133. Taiwan Medication Sales, by Type Million Units (2013-2018)
  • Table 134. Taiwan Medication Sales, by Application Million Units (2013-2018)
  • Table 135. Taiwan Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 136. Australia Medication Sales, by Type Million Units (2013-2018)
  • Table 137. Australia Medication Sales, by Application Million Units (2013-2018)
  • Table 138. Australia Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 139. Rest of Asia-Pacific Medication Sales, by Type Million Units (2013-2018)
  • Table 140. Rest of Asia-Pacific Medication Sales, by Application Million Units (2013-2018)
  • Table 141. Rest of Asia-Pacific Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 142. Europe Medication Sales, by Country Million Units (2013-2018)
  • Table 143. Europe Medication Sales, by Type Million Units (2013-2018)
  • Table 144. Europe Medication Sales, by Application Million Units (2013-2018)
  • Table 145. Europe Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 146. Germany Medication Sales, by Type Million Units (2013-2018)
  • Table 147. Germany Medication Sales, by Application Million Units (2013-2018)
  • Table 148. Germany Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 149. France Medication Sales, by Type Million Units (2013-2018)
  • Table 150. France Medication Sales, by Application Million Units (2013-2018)
  • Table 151. France Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 152. Italy Medication Sales, by Type Million Units (2013-2018)
  • Table 153. Italy Medication Sales, by Application Million Units (2013-2018)
  • Table 154. Italy Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 155. United Kingdom Medication Sales, by Type Million Units (2013-2018)
  • Table 156. United Kingdom Medication Sales, by Application Million Units (2013-2018)
  • Table 157. United Kingdom Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 158. Netherlands Medication Sales, by Type Million Units (2013-2018)
  • Table 159. Netherlands Medication Sales, by Application Million Units (2013-2018)
  • Table 160. Netherlands Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 161. Rest of Europe Medication Sales, by Type Million Units (2013-2018)
  • Table 162. Rest of Europe Medication Sales, by Application Million Units (2013-2018)
  • Table 163. Rest of Europe Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 164. MEA Medication Sales, by Country Million Units (2013-2018)
  • Table 165. MEA Medication Sales, by Type Million Units (2013-2018)
  • Table 166. MEA Medication Sales, by Application Million Units (2013-2018)
  • Table 167. MEA Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 168. Middle East Medication Sales, by Type Million Units (2013-2018)
  • Table 169. Middle East Medication Sales, by Application Million Units (2013-2018)
  • Table 170. Middle East Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 171. Africa Medication Sales, by Type Million Units (2013-2018)
  • Table 172. Africa Medication Sales, by Application Million Units (2013-2018)
  • Table 173. Africa Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 174. North America Medication Sales, by Country Million Units (2013-2018)
  • Table 175. North America Medication Sales, by Type Million Units (2013-2018)
  • Table 176. North America Medication Sales, by Application Million Units (2013-2018)
  • Table 177. North America Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 178. United States Medication Sales, by Type Million Units (2013-2018)
  • Table 179. United States Medication Sales, by Application Million Units (2013-2018)
  • Table 180. United States Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 181. Canada Medication Sales, by Type Million Units (2013-2018)
  • Table 182. Canada Medication Sales, by Application Million Units (2013-2018)
  • Table 183. Canada Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 184. Mexico Medication Sales, by Type Million Units (2013-2018)
  • Table 185. Mexico Medication Sales, by Application Million Units (2013-2018)
  • Table 186. Mexico Medication Sales, by Sales Channels Million Units (2013-2018)
  • Table 187. Medication: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Medication: by Type(USD Million)
  • Table 199. Medication Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics) , by Region USD Million (2019-2024)
  • Table 200. Medication Formulations (Chronic, Acute) , by Region USD Million (2019-2024)
  • Table 201. Medication: by Application(USD Million)
  • Table 202. Medication Hospital , by Region USD Million (2019-2024)
  • Table 203. Medication Clinic , by Region USD Million (2019-2024)
  • Table 204. Medication Other , by Region USD Million (2019-2024)
  • Table 205. Medication: by Sales Channels(USD Million)
  • Table 206. Medication Online Sales Channels , by Region USD Million (2019-2024)
  • Table 207. Medication Offline Sales Channels , by Region USD Million (2019-2024)
  • Table 208. South America Medication, by Country USD Million (2019-2024)
  • Table 209. South America Medication, by Type USD Million (2019-2024)
  • Table 210. South America Medication, by Application USD Million (2019-2024)
  • Table 211. South America Medication, by Sales Channels USD Million (2019-2024)
  • Table 212. Brazil Medication, by Type USD Million (2019-2024)
  • Table 213. Brazil Medication, by Application USD Million (2019-2024)
  • Table 214. Brazil Medication, by Sales Channels USD Million (2019-2024)
  • Table 215. Argentina Medication, by Type USD Million (2019-2024)
  • Table 216. Argentina Medication, by Application USD Million (2019-2024)
  • Table 217. Argentina Medication, by Sales Channels USD Million (2019-2024)
  • Table 218. Rest of South America Medication, by Type USD Million (2019-2024)
  • Table 219. Rest of South America Medication, by Application USD Million (2019-2024)
  • Table 220. Rest of South America Medication, by Sales Channels USD Million (2019-2024)
  • Table 221. Asia Pacific Medication, by Country USD Million (2019-2024)
  • Table 222. Asia Pacific Medication, by Type USD Million (2019-2024)
  • Table 223. Asia Pacific Medication, by Application USD Million (2019-2024)
  • Table 224. Asia Pacific Medication, by Sales Channels USD Million (2019-2024)
  • Table 225. China Medication, by Type USD Million (2019-2024)
  • Table 226. China Medication, by Application USD Million (2019-2024)
  • Table 227. China Medication, by Sales Channels USD Million (2019-2024)
  • Table 228. Japan Medication, by Type USD Million (2019-2024)
  • Table 229. Japan Medication, by Application USD Million (2019-2024)
  • Table 230. Japan Medication, by Sales Channels USD Million (2019-2024)
  • Table 231. India Medication, by Type USD Million (2019-2024)
  • Table 232. India Medication, by Application USD Million (2019-2024)
  • Table 233. India Medication, by Sales Channels USD Million (2019-2024)
  • Table 234. South Korea Medication, by Type USD Million (2019-2024)
  • Table 235. South Korea Medication, by Application USD Million (2019-2024)
  • Table 236. South Korea Medication, by Sales Channels USD Million (2019-2024)
  • Table 237. Taiwan Medication, by Type USD Million (2019-2024)
  • Table 238. Taiwan Medication, by Application USD Million (2019-2024)
  • Table 239. Taiwan Medication, by Sales Channels USD Million (2019-2024)
  • Table 240. Australia Medication, by Type USD Million (2019-2024)
  • Table 241. Australia Medication, by Application USD Million (2019-2024)
  • Table 242. Australia Medication, by Sales Channels USD Million (2019-2024)
  • Table 243. Rest of Asia-Pacific Medication, by Type USD Million (2019-2024)
  • Table 244. Rest of Asia-Pacific Medication, by Application USD Million (2019-2024)
  • Table 245. Rest of Asia-Pacific Medication, by Sales Channels USD Million (2019-2024)
  • Table 246. Europe Medication, by Country USD Million (2019-2024)
  • Table 247. Europe Medication, by Type USD Million (2019-2024)
  • Table 248. Europe Medication, by Application USD Million (2019-2024)
  • Table 249. Europe Medication, by Sales Channels USD Million (2019-2024)
  • Table 250. Germany Medication, by Type USD Million (2019-2024)
  • Table 251. Germany Medication, by Application USD Million (2019-2024)
  • Table 252. Germany Medication, by Sales Channels USD Million (2019-2024)
  • Table 253. France Medication, by Type USD Million (2019-2024)
  • Table 254. France Medication, by Application USD Million (2019-2024)
  • Table 255. France Medication, by Sales Channels USD Million (2019-2024)
  • Table 256. Italy Medication, by Type USD Million (2019-2024)
  • Table 257. Italy Medication, by Application USD Million (2019-2024)
  • Table 258. Italy Medication, by Sales Channels USD Million (2019-2024)
  • Table 259. United Kingdom Medication, by Type USD Million (2019-2024)
  • Table 260. United Kingdom Medication, by Application USD Million (2019-2024)
  • Table 261. United Kingdom Medication, by Sales Channels USD Million (2019-2024)
  • Table 262. Netherlands Medication, by Type USD Million (2019-2024)
  • Table 263. Netherlands Medication, by Application USD Million (2019-2024)
  • Table 264. Netherlands Medication, by Sales Channels USD Million (2019-2024)
  • Table 265. Rest of Europe Medication, by Type USD Million (2019-2024)
  • Table 266. Rest of Europe Medication, by Application USD Million (2019-2024)
  • Table 267. Rest of Europe Medication, by Sales Channels USD Million (2019-2024)
  • Table 268. MEA Medication, by Country USD Million (2019-2024)
  • Table 269. MEA Medication, by Type USD Million (2019-2024)
  • Table 270. MEA Medication, by Application USD Million (2019-2024)
  • Table 271. MEA Medication, by Sales Channels USD Million (2019-2024)
  • Table 272. Middle East Medication, by Type USD Million (2019-2024)
  • Table 273. Middle East Medication, by Application USD Million (2019-2024)
  • Table 274. Middle East Medication, by Sales Channels USD Million (2019-2024)
  • Table 275. Africa Medication, by Type USD Million (2019-2024)
  • Table 276. Africa Medication, by Application USD Million (2019-2024)
  • Table 277. Africa Medication, by Sales Channels USD Million (2019-2024)
  • Table 278. North America Medication, by Country USD Million (2019-2024)
  • Table 279. North America Medication, by Type USD Million (2019-2024)
  • Table 280. North America Medication, by Application USD Million (2019-2024)
  • Table 281. North America Medication, by Sales Channels USD Million (2019-2024)
  • Table 282. United States Medication, by Type USD Million (2019-2024)
  • Table 283. United States Medication, by Application USD Million (2019-2024)
  • Table 284. United States Medication, by Sales Channels USD Million (2019-2024)
  • Table 285. Canada Medication, by Type USD Million (2019-2024)
  • Table 286. Canada Medication, by Application USD Million (2019-2024)
  • Table 287. Canada Medication, by Sales Channels USD Million (2019-2024)
  • Table 288. Mexico Medication, by Type USD Million (2019-2024)
  • Table 289. Mexico Medication, by Application USD Million (2019-2024)
  • Table 290. Mexico Medication, by Sales Channels USD Million (2019-2024)
  • Table 291. Medication Sales: by Type(Million Units)
  • Table 292. Medication Sales Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics) , by Region Million Units (2019-2024)
  • Table 293. Medication Sales Formulations (Chronic, Acute) , by Region Million Units (2019-2024)
  • Table 294. Medication Sales: by Application(Million Units)
  • Table 295. Medication Sales Hospital , by Region Million Units (2019-2024)
  • Table 296. Medication Sales Clinic , by Region Million Units (2019-2024)
  • Table 297. Medication Sales Other , by Region Million Units (2019-2024)
  • Table 298. Medication Sales: by Sales Channels(Million Units)
  • Table 299. Medication Sales Online Sales Channels , by Region Million Units (2019-2024)
  • Table 300. Medication Sales Offline Sales Channels , by Region Million Units (2019-2024)
  • Table 301. South America Medication Sales, by Country Million Units (2019-2024)
  • Table 302. South America Medication Sales, by Type Million Units (2019-2024)
  • Table 303. South America Medication Sales, by Application Million Units (2019-2024)
  • Table 304. South America Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 305. Brazil Medication Sales, by Type Million Units (2019-2024)
  • Table 306. Brazil Medication Sales, by Application Million Units (2019-2024)
  • Table 307. Brazil Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 308. Argentina Medication Sales, by Type Million Units (2019-2024)
  • Table 309. Argentina Medication Sales, by Application Million Units (2019-2024)
  • Table 310. Argentina Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 311. Rest of South America Medication Sales, by Type Million Units (2019-2024)
  • Table 312. Rest of South America Medication Sales, by Application Million Units (2019-2024)
  • Table 313. Rest of South America Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 314. Asia Pacific Medication Sales, by Country Million Units (2019-2024)
  • Table 315. Asia Pacific Medication Sales, by Type Million Units (2019-2024)
  • Table 316. Asia Pacific Medication Sales, by Application Million Units (2019-2024)
  • Table 317. Asia Pacific Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 318. China Medication Sales, by Type Million Units (2019-2024)
  • Table 319. China Medication Sales, by Application Million Units (2019-2024)
  • Table 320. China Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 321. Japan Medication Sales, by Type Million Units (2019-2024)
  • Table 322. Japan Medication Sales, by Application Million Units (2019-2024)
  • Table 323. Japan Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 324. India Medication Sales, by Type Million Units (2019-2024)
  • Table 325. India Medication Sales, by Application Million Units (2019-2024)
  • Table 326. India Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 327. South Korea Medication Sales, by Type Million Units (2019-2024)
  • Table 328. South Korea Medication Sales, by Application Million Units (2019-2024)
  • Table 329. South Korea Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 330. Taiwan Medication Sales, by Type Million Units (2019-2024)
  • Table 331. Taiwan Medication Sales, by Application Million Units (2019-2024)
  • Table 332. Taiwan Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 333. Australia Medication Sales, by Type Million Units (2019-2024)
  • Table 334. Australia Medication Sales, by Application Million Units (2019-2024)
  • Table 335. Australia Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 336. Rest of Asia-Pacific Medication Sales, by Type Million Units (2019-2024)
  • Table 337. Rest of Asia-Pacific Medication Sales, by Application Million Units (2019-2024)
  • Table 338. Rest of Asia-Pacific Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 339. Europe Medication Sales, by Country Million Units (2019-2024)
  • Table 340. Europe Medication Sales, by Type Million Units (2019-2024)
  • Table 341. Europe Medication Sales, by Application Million Units (2019-2024)
  • Table 342. Europe Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 343. Germany Medication Sales, by Type Million Units (2019-2024)
  • Table 344. Germany Medication Sales, by Application Million Units (2019-2024)
  • Table 345. Germany Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 346. France Medication Sales, by Type Million Units (2019-2024)
  • Table 347. France Medication Sales, by Application Million Units (2019-2024)
  • Table 348. France Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 349. Italy Medication Sales, by Type Million Units (2019-2024)
  • Table 350. Italy Medication Sales, by Application Million Units (2019-2024)
  • Table 351. Italy Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 352. United Kingdom Medication Sales, by Type Million Units (2019-2024)
  • Table 353. United Kingdom Medication Sales, by Application Million Units (2019-2024)
  • Table 354. United Kingdom Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 355. Netherlands Medication Sales, by Type Million Units (2019-2024)
  • Table 356. Netherlands Medication Sales, by Application Million Units (2019-2024)
  • Table 357. Netherlands Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 358. Rest of Europe Medication Sales, by Type Million Units (2019-2024)
  • Table 359. Rest of Europe Medication Sales, by Application Million Units (2019-2024)
  • Table 360. Rest of Europe Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 361. MEA Medication Sales, by Country Million Units (2019-2024)
  • Table 362. MEA Medication Sales, by Type Million Units (2019-2024)
  • Table 363. MEA Medication Sales, by Application Million Units (2019-2024)
  • Table 364. MEA Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 365. Middle East Medication Sales, by Type Million Units (2019-2024)
  • Table 366. Middle East Medication Sales, by Application Million Units (2019-2024)
  • Table 367. Middle East Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 368. Africa Medication Sales, by Type Million Units (2019-2024)
  • Table 369. Africa Medication Sales, by Application Million Units (2019-2024)
  • Table 370. Africa Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 371. North America Medication Sales, by Country Million Units (2019-2024)
  • Table 372. North America Medication Sales, by Type Million Units (2019-2024)
  • Table 373. North America Medication Sales, by Application Million Units (2019-2024)
  • Table 374. North America Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 375. United States Medication Sales, by Type Million Units (2019-2024)
  • Table 376. United States Medication Sales, by Application Million Units (2019-2024)
  • Table 377. United States Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 378. Canada Medication Sales, by Type Million Units (2019-2024)
  • Table 379. Canada Medication Sales, by Application Million Units (2019-2024)
  • Table 380. Canada Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 381. Mexico Medication Sales, by Type Million Units (2019-2024)
  • Table 382. Mexico Medication Sales, by Application Million Units (2019-2024)
  • Table 383. Mexico Medication Sales, by Sales Channels Million Units (2019-2024)
  • Table 384. Medication: by Type(USD/Units)
  • Table 385. Research Programs/Design for This Report
  • Table 386. Key Data Information from Secondary Sources
  • Table 387. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medication: by Type USD Million (2013-2018)
  • Figure 5. Global Medication: by Application USD Million (2013-2018)
  • Figure 6. Global Medication: by Sales Channels USD Million (2013-2018)
  • Figure 7. South America Medication Share (%), by Country
  • Figure 8. Asia Pacific Medication Share (%), by Country
  • Figure 9. Europe Medication Share (%), by Country
  • Figure 10. MEA Medication Share (%), by Country
  • Figure 11. North America Medication Share (%), by Country
  • Figure 12. Global Medication: by Type Million Units (2013-2018)
  • Figure 13. Global Medication: by Application Million Units (2013-2018)
  • Figure 14. Global Medication: by Sales Channels Million Units (2013-2018)
  • Figure 15. South America Medication Share (%), by Country
  • Figure 16. Asia Pacific Medication Share (%), by Country
  • Figure 17. Europe Medication Share (%), by Country
  • Figure 18. MEA Medication Share (%), by Country
  • Figure 19. North America Medication Share (%), by Country
  • Figure 20. Global Medication: by Type USD/Units (2013-2018)
  • Figure 21. Global Medication share by Players 2018 (%)
  • Figure 22. Global Medication share by Players (Top 3) 2018(%)
  • Figure 23. Global Medication share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 26. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 27. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis (Switzerland) Revenue: by Geography 2018
  • Figure 29. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Roche Holding AG (Switzerland) Revenue: by Geography 2018
  • Figure 31. Pfizer (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Pfizer (Switzerland) Revenue: by Geography 2018
  • Figure 33. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 34. Sanofi (France) Revenue: by Geography 2018
  • Figure 35. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 36. Merck (United States) Revenue: by Geography 2018
  • Figure 37. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2018
  • Figure 39. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. AstraZeneca (United Kingdom) Revenue: by Geography 2018
  • Figure 41. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Bayer (Germany) Revenue: by Geography 2018
  • Figure 43. Gilead Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 44. Gilead Sciences (United States) Revenue: by Geography 2018
  • Figure 45. Global Medication: by Type USD Million (2019-2024)
  • Figure 46. Global Medication: by Application USD Million (2019-2024)
  • Figure 47. Global Medication: by Sales Channels USD Million (2019-2024)
  • Figure 48. South America Medication Share (%), by Country
  • Figure 49. Asia Pacific Medication Share (%), by Country
  • Figure 50. Europe Medication Share (%), by Country
  • Figure 51. MEA Medication Share (%), by Country
  • Figure 52. North America Medication Share (%), by Country
  • Figure 53. Global Medication: by Type Million Units (2019-2024)
  • Figure 54. Global Medication: by Application Million Units (2019-2024)
  • Figure 55. Global Medication: by Sales Channels Million Units (2019-2024)
  • Figure 56. South America Medication Share (%), by Country
  • Figure 57. Asia Pacific Medication Share (%), by Country
  • Figure 58. Europe Medication Share (%), by Country
  • Figure 59. MEA Medication Share (%), by Country
  • Figure 60. North America Medication Share (%), by Country
  • Figure 61. Global Medication: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Novartis (Switzerland)
  • Roche Holding AG (Switzerland)
  • Pfizer (Switzerland)
  • Sanofi (France)
  • Merck (United States)
  • GlaxoSmithKline (United Kingdom)
  • AstraZeneca (United Kingdom)
  • Bayer (Germany)
  • Gilead Sciences (United States)
Additional players considered in the study are as follows:
Amgen (United States) , AstraZeneca (United Kingdom) , Bristol-Myers Squibb (United States) , Eli Lilly (United States) , Teva Pharmaceutical (Israel) , Novo Nordisk (Denmark) , Allergan (Ireland) , Shire (United States) , Takeda (Japan)
Select User Access Type

Key Highlights of Report


Aug 2019 222 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medication Quantitative research analysis
Global Medication Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Medication Report?

Have a Query? Click Here

Other Related Reports

Orthopedic Cartilage Repair Comprehensive Study by Type (ACL/PCL, Meniscal Repair, Rotator Cuff, Shoulder Labarum, Hip Arthroscopy, Biceps Tenodesis), Application (Knee, Hip, Shoulder, Others), End U...
$ 3450
Medical Screen Comprehensive Study by Type (Portable, Fixed), Application (Private Clinics, Hospitals, Nursing Homes, Specialty Care Centers), Frame Type (Aluminum, Steel), Number of Panels (One, Two...
$ 3450
Whey Protein Isolate Comprehensive Study by Type (Flavored, Unflavored), Application (Dietary Supplements, Functional Beverages, Functional Food, Others), Distribution Channel (Online, Offline {Hyper...
$ 3650
Ultrasound Gel Warmer Comprehensive Study by Type (Single Bottle Ultrasound Gel Warmer, Two Bottle Ultrasound Gel Warmer, Three Bottle Ultrasound Gel Warmer), Application (Hospital, Clinics, Diagnost...
$ 3650
Wound Retractor Comprehensive Study by Type (Metal Wound Retractor, Plastic Wound Retractor), Application (Hospital, Clinics, Ambulatory Surgical Centres, Others), Distribution Channel (Online Channe...
$ 3800
Hydration Products Comprehensive Study by Type (Hydration Packs, Water Bottles, Purification and Filtration, Accessories, Other), Application (Sports, Military, Other), Technology Types (Thermoplasti...
$ 3650